| Aiea Internal Medicine Services, L.l.c. | |
|
98-1079 Moanalua Rd Suite 350 Aiea HI 96701-4713 | |
| (808) 487-2277 | |
| (808) 488-5582 |
| Full Name | Aiea Internal Medicine Services, L.l.c. |
|---|---|
| Speciality | Internal Medicine |
| Location | 98-1079 Moanalua Rd, Aiea, Hawaii |
| Authorized Official Name and Position | Dawn A Miura (PHYSICIAN) |
| Authorized Official Contact | 8084872277 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Aiea Internal Medicine Services, L.l.c. 98-1079 Moanalua Rd Suite 350 Aiea HI 96701-4713 Ph: (808) 487-2277 | Aiea Internal Medicine Services, L.l.c. 98-1079 Moanalua Rd Suite 350 Aiea HI 96701-4713 Ph: (808) 487-2277 |
| NPI Number | 1598773657 |
|---|---|
| Provider Enumeration Date | 08/04/2006 |
| Last Update Date | 11/26/2007 |
| Medicare PECOS PAC ID | 6305737172 |
|---|---|
| Medicare Enrollment ID | O20040322001277 |
News Archive
Case Western Reserve University researchers have developed a portable sensor that can assess the clotting ability of a person's blood 95 times faster than current methods—using only a single drop of blood.
Arena Pharmaceuticals, Inc. announced today that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA). Arena submitted the lorcaserin NDA on December 22, 2009, and expects to learn the Prescription Drug User Fee Act (PDUFA) date in the next few weeks. The PDUFA date is the target date for the FDA to complete its review of an NDA.
The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will provide up to an estimated $11 million over the next five years to create two new Biomedical Technology Research Centers (BTRCs) that will provide researchers nationwide with access to specialized research tools, training and state-of-the-art equipment.
Congressional Republicans are releasing two health care reform proposals - one from conservatives and one from moderates - as alternatives to plans by Democrats, CQ Today reports (Wayne, CQ Today, 5/19).
Immune cells called CD4+ T cells could be important mediators of protection against the Zika virus, according to a study published January 24 in the open-access journal PLOS Pathogens by Sujan Shresta of the La Jolla Institute for Allergy and Immunology, and colleagues.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598773657 | NPI | - | NPPES |
| 52327 | Other | HI | GROUP NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Dawn A Miura |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003824160 PECOS PAC ID: 0446141220 Enrollment ID: I20100907001082 |
News Archive
Case Western Reserve University researchers have developed a portable sensor that can assess the clotting ability of a person's blood 95 times faster than current methods—using only a single drop of blood.
Arena Pharmaceuticals, Inc. announced today that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA). Arena submitted the lorcaserin NDA on December 22, 2009, and expects to learn the Prescription Drug User Fee Act (PDUFA) date in the next few weeks. The PDUFA date is the target date for the FDA to complete its review of an NDA.
The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will provide up to an estimated $11 million over the next five years to create two new Biomedical Technology Research Centers (BTRCs) that will provide researchers nationwide with access to specialized research tools, training and state-of-the-art equipment.
Congressional Republicans are releasing two health care reform proposals - one from conservatives and one from moderates - as alternatives to plans by Democrats, CQ Today reports (Wayne, CQ Today, 5/19).
Immune cells called CD4+ T cells could be important mediators of protection against the Zika virus, according to a study published January 24 in the open-access journal PLOS Pathogens by Sujan Shresta of the La Jolla Institute for Allergy and Immunology, and colleagues.
› Verified 6 days ago
| Provider Name | David M Saito |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1457369514 PECOS PAC ID: 3971494758 Enrollment ID: I20100916000268 |
News Archive
Case Western Reserve University researchers have developed a portable sensor that can assess the clotting ability of a person's blood 95 times faster than current methods—using only a single drop of blood.
Arena Pharmaceuticals, Inc. announced today that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA). Arena submitted the lorcaserin NDA on December 22, 2009, and expects to learn the Prescription Drug User Fee Act (PDUFA) date in the next few weeks. The PDUFA date is the target date for the FDA to complete its review of an NDA.
The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will provide up to an estimated $11 million over the next five years to create two new Biomedical Technology Research Centers (BTRCs) that will provide researchers nationwide with access to specialized research tools, training and state-of-the-art equipment.
Congressional Republicans are releasing two health care reform proposals - one from conservatives and one from moderates - as alternatives to plans by Democrats, CQ Today reports (Wayne, CQ Today, 5/19).
Immune cells called CD4+ T cells could be important mediators of protection against the Zika virus, according to a study published January 24 in the open-access journal PLOS Pathogens by Sujan Shresta of the La Jolla Institute for Allergy and Immunology, and colleagues.
› Verified 6 days ago
| Provider Name | Russell M Tom |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1346258407 PECOS PAC ID: 2769373547 Enrollment ID: I20101214000905 |
News Archive
Case Western Reserve University researchers have developed a portable sensor that can assess the clotting ability of a person's blood 95 times faster than current methods—using only a single drop of blood.
Arena Pharmaceuticals, Inc. announced today that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA). Arena submitted the lorcaserin NDA on December 22, 2009, and expects to learn the Prescription Drug User Fee Act (PDUFA) date in the next few weeks. The PDUFA date is the target date for the FDA to complete its review of an NDA.
The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will provide up to an estimated $11 million over the next five years to create two new Biomedical Technology Research Centers (BTRCs) that will provide researchers nationwide with access to specialized research tools, training and state-of-the-art equipment.
Congressional Republicans are releasing two health care reform proposals - one from conservatives and one from moderates - as alternatives to plans by Democrats, CQ Today reports (Wayne, CQ Today, 5/19).
Immune cells called CD4+ T cells could be important mediators of protection against the Zika virus, according to a study published January 24 in the open-access journal PLOS Pathogens by Sujan Shresta of the La Jolla Institute for Allergy and Immunology, and colleagues.
› Verified 6 days ago
News Archive
Case Western Reserve University researchers have developed a portable sensor that can assess the clotting ability of a person's blood 95 times faster than current methods—using only a single drop of blood.
Arena Pharmaceuticals, Inc. announced today that its New Drug Application (NDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA). Arena submitted the lorcaserin NDA on December 22, 2009, and expects to learn the Prescription Drug User Fee Act (PDUFA) date in the next few weeks. The PDUFA date is the target date for the FDA to complete its review of an NDA.
The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will provide up to an estimated $11 million over the next five years to create two new Biomedical Technology Research Centers (BTRCs) that will provide researchers nationwide with access to specialized research tools, training and state-of-the-art equipment.
Congressional Republicans are releasing two health care reform proposals - one from conservatives and one from moderates - as alternatives to plans by Democrats, CQ Today reports (Wayne, CQ Today, 5/19).
Immune cells called CD4+ T cells could be important mediators of protection against the Zika virus, according to a study published January 24 in the open-access journal PLOS Pathogens by Sujan Shresta of the La Jolla Institute for Allergy and Immunology, and colleagues.
› Verified 6 days ago
Rice Consultancy Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 98-211 Pali Momi St, Suite 312, Aiea, HI 96701 Phone: 808-486-0449 Fax: 808-488-0725 | |
Ky Le Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 808-536-0300 | |
Yousif A-rahim Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 98-211 Pali Momi St, 312, Aiea, HI 96701 Phone: 808-486-0449 Fax: 808-488-0725 | |
Luis J. Ragunton, M.d., Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 98-1079 Moanalua Rd, Suite 440, Aiea, HI 96701 Phone: 808-488-8750 Fax: 808-487-5910 | |
Mark A Morisaki Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 98-1079 Moanalua Rd Ste 620, Aiea, HI 96701 Phone: 808-488-2224 | |
Randall J. Nitta, Md, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 98-1247 Kaahumanu St Ste 306, Aiea, HI 96701 Phone: 808-484-2904 Fax: 808-484-2864 | |
Robert Wong, Md, L.l.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 98-211 Pali Momi Street, Suite 312, Aiea, HI 96701 Phone: 808-486-0449 Fax: 808-488-0725 |